Avis Budget Stock Plunges After Worse-Than-Expected Q1 2026 Loss
Avis Budget Group shares plunged after a worse-than-expected Q1 2026 loss of $8.01 per share versus estimates, while revenue rose slightly.
Avis Budget Group shares plunged after a worse-than-expected Q1 2026 loss of $8.01 per share versus estimates, while revenue rose slightly.
SoFi had strong Q1 profits, record loans and users, but stock fell as results met expectations and outlook was steady.
Etsy beat Q1 forecasts as sales grew, more buyers spent slightly more, and it stays strong despite inflation and tariffs.
Humana beat Q1 2026 expectations, revenue rose, Medicare membership grew, outlook steady but GAAP cut due to lower ratings.
Corbus Pharmaceuticals gets Buy rating ($45 target). Drug CRB-701 shows strong cancer results, safer than rivals. Stock down 43% may be opportunity.
Booking beat earnings with strong growth, despite Middle East impact; expects modest Q2 and recovery later in 2026.